Cancer Letters
Volume 222, Issue 1 , Pages 83-88 , 10 May 2005

Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer

  • A. Dettlaff-Pokora

      Affiliations

    • Department of Biochemistry, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland
    • ,
  • M. Matuszewski

      Affiliations

    • Department of Urology, Medical University of Gdansk, Kieturakisa 1, 80-742 Gdansk, Poland
    • ,
  • B. Schlichtholz

      Affiliations

    • Department of Biochemistry, Medical University of Gdansk, Debinki 1, 80-211 Gdansk, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 58 349 14 72; fax: +48 58 349 14 65.

Received 5 March 2004 ,Revised 5 September 2004 ,Accepted 7 September 2004.

References 

  1. Moyzis RK, Buckingham JM, Cram S, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence (TTAGGG)n present at the telomere of human chromosomes. Proc. Natl Acad. Sci. USA. 1988;85:6622–6626
  2. Blackburn EH. Structure and function of telomere. Nature (London). 1991;350:569–573
  3. Allsopp RC, Vaziri H, Patterson C, Goldstain S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA. 1992;89:10114–10118
  4. Harley CB. Telomere loss: mitotic clock or genetic time bomb?. Mutat. Res. 1991;256:271–282
  5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352
  6. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J. Mol. Biol. 1992;225:951–960
  7. Hiyama K, Harai Y, Kyozumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 1995;155:3711–3715
  8. Buchkovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell. 1996;7:1443–1454
  9. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, et al. Telomerase activity in normal human epithelial cells. Oncogene. 1996;13:433–439
  10. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl Acad. Sci. USA. 1996;93:6476–6481
  11. Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, Nair MK, et al. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol. Biomarkers Prev. 1997;6:413–420
  12. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  13. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J. Natl Cancer Inst. 1996;88:116–122
  14. Kyo S, Ueno H, Kanaya T, Inoue M. Telomerase activity in gynecological tumors. Clin. Cancer Res. 1996;2:2023–2028
  15. Kyo S, Kunimi K, Uchibayashi T, Namiki M, Inoue M. Telomerase activity in human urothelial tumors. Am. J. Clin. Pathol. 1997;5:555–569
  16. Shay HW, Werbin H, Wright T. Telomerase assays in the diagnosis and prognosis of cancer. Ciba Found Symp. 1997;211:148–155
  17. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBCAN 2000: Cancer incidence, Mortality and Prevalence Worldwide, Version 1.0, IARC CancerBase No. 5.. Lyon: IARC Press; 2001;
  18. Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J. Urol. 1993;150:60–64
  19. Saad A, Hanbury DC, McNicholas TA, Boustead GB, Morgan S, Woodman AC. A study comparing various noninvasive methods of detecting bladder cancer in urine. Br. J. Urol. Int. 2002;89:369–373
  20. Kavaler E, Landman J, Chang Y, Droller MJ, Liu BC. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer. 1998;82:708–714
  21. Heine B, Hummel M, Muller M, Heicappell R, Miller K, Stein H. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J. Pathol. 1998;184:71–76
  22. Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803–1804
  23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254
  24. Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, et al. Comparison of screening methods in the detection of bladder cancer. J. Urol. 1999;161:388–394
  25. Kinoshita H, Ogawa O, Kakehi Y, Mishina M, Mitsumori K, Itoh N, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. Natl Cancer Inst. 1997;89:724–730
  26. Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, et al. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J. Urol. 2002;167:2001–2006
  27. Bialkowska-Hobrzanska H, Bowles L, Bukala B, Joseph MG, Fletcher R, Razvi H. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol. Diagn. 2000;5:267–277
  28. Wu YY, Hruszkewycz AM, Delgado RM, Yang A, Vortmeyer AO, Moon YW, et al. Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin. Chim. Acta. 2000;293:199–212
  29. Arai Y, Yajima T, Yagihashi A, Kobayashi D, Kameshima H, Sasaki M, et al. Limitations of urinary telomerase activity measurement in urothelial cancer. Clin. Chim. Acta. 2000;296:35–44
  30. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 1997;79:362–369
  31. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res. 1995;55:3258–3262
  32. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, et al. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. J. Pathol. 2002;198:181–189
  33. Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. Clin. Cancer Res. 2002;8:2883–2889
  34. Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am. J. Pathol. 2003;162:1019–1026
  35. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin. Cancer Res. 2000;6:2696–2701
  36. Wu XX, Kakehi Y, Nishiyama H, Habuchi T, Ogawa O. Telomerase activity in urine after transurethral resection is not a predictive marker for recurrence of superficial bladder cancer. Int. J. Urol. 2003;10:117–118

PII: S0304-3835(04)00708-6

doi: 10.1016/j.canlet.2004.09.004

Cancer Letters
Volume 222, Issue 1 , Pages 83-88 , 10 May 2005

Article Tools